### ðŸ« Lung Cancer Dataset

The **Lung Cancer dataset** used in this study was extracted from the **Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial**, a large-scale, multi-year study conducted by the U.S. National Cancer Institute (NCI).

ðŸ“„ **References**:  
- Prorok et al., 2000 â€” *Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial*  
- Gohagan et al., 2000 â€” *The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute*

ðŸ”— [PLCO official resource page](https://biometry.nci.nih.gov/cdas/plco/)

---

#### ðŸ“‘ Description

This dataset provides a rich source of **demographic, behavioral, clinical, and lifestyle variables** collected from over 150,000 participants across the U.S. It includes variables such as:

- Age, gender, and smoking status
- Screening test results and follow-up diagnostics
- Family history of cancer
- Medical history and vital statistics

The data is commonly used for:
- **Early detection research**
- **Risk prediction modeling**
- **Survival analysis**
- **Feature selection in ML models related to cancer prognosis**

> ðŸ“Ž Due to the sensitive nature of the dataset, researchers must apply for access through the NCI's Cancer Data Access System (CDAS).

---

#### ðŸ“Š Use in This Study

We selected this dataset to evaluate predictive models in the context of lung cancer detection and to validate features related to lifestyle risk factors and screening outcomes.
